Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer

被引:0
|
作者
Lisa M. C. van Hoogstraten
Calvin C. O. Man
J. Alfred Witjes
Richard P. Meijer
Sasja F. Mulder
Tineke J. Smilde
Theodora M. Ripping
Lambertus A. Kiemeney
Katja K. H. Aben
机构
[1] Netherlands Comprehensive Cancer Organisation,Radboud Institute for Health Sciences
[2] Radboud University Medical Centre,Department of Urology
[3] Radboud University Medical Centre,Department of Oncological Urology
[4] University Medical Centre Utrecht,Department of Medical Oncology
[5] Radboud University Medical Centre,Department of Medical Oncology
[6] Jeroen Bosch Hospital,undefined
来源
World Journal of Urology | 2023年 / 41卷
关键词
Bladder carcinoma; Guideline adherence; MIBC; Muscle-invasive bladder cancer; Neoadjuvant chemotherapy; Radical cystectomy; Variation in healthcare;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1837 / 1845
页数:8
相关论文
共 50 条
  • [1] Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer
    van Hoogstraten, Lisa M. C.
    Man, Calvin C. O. L.
    Witjes, J. Alfred R.
    Meijer, Richard M.
    Mulder, Sasja
    Smilde, Tineke
    Ripping, Theodora
    Kiemeney, Lambertus P.
    Aben, Katja K. H.
    BlaZIB Study Grp
    WORLD JOURNAL OF UROLOGY, 2023, 41 (07) : 1837 - 1845
  • [2] Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Carvalho, Filipe L. F.
    Zeymo, Alexander
    Egan, Jillian
    Kelly, Colleen H.
    Zheng, Chaoyi
    Lynch, John H.
    Hwang, Jonathan
    Stamatakis, Lambros
    Krasnow, Ross E.
    Kowalczyk, Keith J.
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (04) : 390 - 396
  • [3] Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Calabro, Fabio
    Sternberg, Cora N.
    EUROPEAN UROLOGY, 2009, 55 (02) : 348 - 358
  • [4] Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Marcq, Gautier
    Jarry, Edouard
    Ouzaid, Idir
    Hermieu, Jean-Francois
    Henon, Francois
    Fantoni, Jean-Christophe
    Xylinas, Evanguelos
    THERAPEUTIC ADVANCES IN UROLOGY, 2019, 11 : 1 - 8
  • [5] Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Faraj, Kassem S.
    Navaratnam, Anojan K.
    Eversman, Sarah
    Elias, Laila
    Syal, Amit
    Tyson, Mark D.
    Castle, Erik P.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (06) : 1111 - 1118
  • [6] Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Kassem S. Faraj
    Anojan K. Navaratnam
    Sarah Eversman
    Laila Elias
    Amit Syal
    Mark D. Tyson
    Erik P. Castle
    International Urology and Nephrology, 2021, 53 : 1111 - 1118
  • [7] Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Lyon, Timothy D.
    Frank, Igor
    Takahashi, Naoki
    Boorjian, Stephen A.
    Moynagh, Michael R.
    Shah, Paras H.
    Tarrell, Robert F.
    Cheville, John C.
    Viers, Boyd R.
    Tollefson, Matthew K.
    CLINICAL GENITOURINARY CANCER, 2019, 17 (03) : 216 - +
  • [8] Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer
    Macleod, Liam C.
    Fam, Mina M.
    Yabes, Jonathan G.
    Hale, Nathan E.
    Turner, Robert M., II
    Lopa, Samia H.
    Gingrich, Jeffrey R.
    Borza, Tudor
    Skolarus, Ted A.
    Davies, Benjamin J.
    Jacobs, Bruce L.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 201 - +
  • [9] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Vasdev, N.
    Zargar, H.
    Fairey, A.
    Espiritu, P.
    Krabbe, L.
    Mongomery, J.
    Gandhi, N.
    Griffin, J.
    Yu, E.
    Campain, N.
    Xylinas, E.
    Horenblas, S.
    Yousef, D.
    Kassouf, W.
    Shariat, S.
    Aning, J.
    Wright, J.
    Holzbeierlein, J.
    Bivalacqua, T.
    Morgan, T.
    North, S.
    Borcas, D.
    Lotan, Y.
    Shah, J.
    Spiess, P.
    Van Rhijn, B.
    Daneshmand, S.
    Black, P.
    Thorpe, A. C.
    BJU INTERNATIONAL, 2014, 113 : 25 - 25
  • [10] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
    Zargar, Homayoun
    Espiritu, Patrick N.
    Fairey, Adrian S.
    Mertens, Laura S.
    Dinney, Colin P.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobsen, Niels-Erik
    Gandhi, Nilay M.
    Griffin, Joshua
    Montgomery, Jeffrey S.
    Vasdev, Nikhil
    Yu, Evan Y.
    Youssef, David
    Xylinas, Evanguelos
    Campain, Nicholas J.
    Kassouf, Wassim
    Dall'Era, Marc A.
    Seah, Jo-An
    Ercole, Cesar E.
    Horenblas, Simon
    Sridhar, Srikala S.
    McGrath, John S.
    Aning, Jonathan
    Shariat, Shahrokh F.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Morgan, Todd M.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Garcia, Jorge A.
    Stephenson, Andrew J.
    Shah, Jay B.
    van Rhijn, Bas W.
    Daneshmand, Siamak
    Spiess, Philippe E.
    Black, Peter C.
    EUROPEAN UROLOGY, 2015, 67 (02) : 241 - 249